Answers are grounded in this paper and cite their sources.
In patients with Type 2 diabetes, well controlled with metformin monotherapy, addition of liraglutide improves several cardiovascular risk markers beyond glycaemic control.
No takes yet. Share an insight, caveat, or question.
Först et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: